HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study.

Saved in:
Bibliographic Details
Title: HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study.
Authors: Qu, Kang1 (AUTHOR), Li, Ming-xi1 (AUTHOR), Yu, Peng2 (AUTHOR), Palotie, Aarno3,4 (AUTHOR), Pressman, Alice5 (AUTHOR), Belin, Andrea C.6 (AUTHOR), Bjornsdottir, Anna7 (AUTHOR), van den Maagdenberg, Arn M. J. M.8,9 (AUTHOR), Harder, Aster V. E.8,9 (AUTHOR), Winsvold, Bendik S.10,11,12 (AUTHOR), Müller-Myhsok, Bertram13 (AUTHOR), Cormand, Bru14 (AUTHOR), Ran, Caroline6 (AUTHOR), Northover, Carrie15 (AUTHOR), Kubisch, Christian16 (AUTHOR), van Duijn, Cornelia17 (AUTHOR), Nyholt, Dale R.18 (AUTHOR), Chasman, Daniel I.19,20 (AUTHOR), Posthuma, Danielle21 (AUTHOR), Lessel, Davor16 (AUTHOR)
Source: Scientific Reports. 5/27/2024, Vol. 14 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-024-61628-9